As described by EU Safety Gate (RAPEX): SL + skin light plus, Suprême Acrive White, Whitening Body Lotion Strong Treatment
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Das Produkt hat eine übermäßige Konzentration von Kojisäure (Messwert: 2,7 %). Kojisäure kann das Gleichgewicht des Schilddrüsensystems beeinträchtigen und auch Hautsensibilisierung hervorrufen, wenn sie in hohen Konzentrationen an Händen und Gesicht oder auf großen Hautpartien angewendet wird. Das Produkt entspricht nicht der Verordnung über kosmetische Mittel.
Action taken by the authority
Type of economic operator taking notified measure
Distributor
Category of measure
Stop of sales
Date of entry into force
05/12/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): SL + skin light plus, Suprême Acrive White, Whitening Body Lotion Strong Treatment
Risk Description (original English): The product has an excessive concentration of kojic acid (measured value: 2.7 %). Kojic acid can affect the balance of the thyroid system and also induce skin sensitisation, when used at high concentrations on hand and face, or if used on large areas of skin.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.